Invesaro

Stocks Health care MCK

NYSE · Health care

McKesson Corp (MCK)

McKesson Corp brought in $411B of revenue over the twelve months to June 30, 2026, up 8.8% from a year earlier. Net income was $4.6B, a net margin of 1.1%. Operating cash flow minus capital spending left $5.7B of free cash flow in fiscal 2026. At June 30, 2026 it held $5.2B in cash against $9.7B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.

Price
$915.45
+1.46% on the day · October 5, 2026
52-week range $723.68 to $999.00
Market cap
$106.7B
Revenue (last 12 months)
$411B
+8.8% year on year
Net margin
1.1%
P/E
23.9
on FY2026 diluted EPS

Key facts about McKesson Corp

Net worth
McKesson Corp has a market value (market cap) of $106.7B at the latest share price, and shareholders' equity of -$4.2B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $403.4B (+12.4% year on year), with net income of $4.8B. Over the 12 months to June 30, 2026: revenue $411B, net income $4.6B.
Cash flow
In fiscal 2026 operations brought in $6.2B of cash; after $436M of capital spending, free cash flow was $5.7B.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
McKesson Corp's next report was expected around September 17, 2026 and is not on file with the SEC yet.
Dividend
McKesson Corp declared dividends of $3.17 per share in fiscal 2026, a yield of 0.35% at the current price.

What McKesson Corp does

McKesson distributes pharmaceuticals, medical supplies, and healthcare technology solutions. It sells prescription drugs and care management tools to retail pharmacies, hospitals, clinics, and health systems. It is known for managing medical supply chains across North America. Its shares trade on NYSE under the ticker MCK.

Revenue and profit by year

Revenue
FY19: $214.3B $214.3B FY19FY20: $231.1B $231.1B FY20FY21: $238.2B $238.2B FY21FY22: $264B $264B FY22FY23: $276.7B $276.7B FY23FY24: $309B $309B FY24FY25: $359.1B $359.1B FY25FY26: $403.4B $403.4B FY26
Net income
FY19: $34M $34M FY19FY20: $900M $900M FY20FY21: -$4.5B -$4.5B FY21FY22: $1.1B $1.1B FY22FY23: $3.6B $3.6B FY23FY24: $3B $3B FY24FY25: $3.3B $3.3B FY25FY26: $4.8B $4.8B FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$403.4B$6.2B$4.8B$38.38$5.7B
2025$359.1B$4.4B$3.3B$25.72$5.5B
2024$309B$3.9B$3B$22.39$3.9B
2023$276.7B$4.4B$3.6B$25.03$4.8B
2022$264B$2B$1.1B$7.23$4B
2021$238.2B-$5B-$4.5B-$28.26$4.1B

Full financial statements: income, balance sheet and cash flow

A report was expected around September 17, 2026 and is not on file yet.

Estimated from its filing rhythm: 52 weeks after its report of September 18, 2025. Not a date the company has announced. See the report calendar

Where MCK ranks in Health care

Revenue$403.4B
#2 of 750 in Health care · Top 1%
Revenue growth+12.4%
#255 of 532 in Health care · Top 48%
Net margin1.2%
#204 of 543 in Health care · Top 37%
Free cash flow margin1.4%
#225 of 489 in Health care · Top 46%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

McKesson Corp declared $3.17 per share in fiscal 2026. At the current price that is a yield of 0.35%. It paid out $381M in cash dividends, 8% of its net income.

Fiscal yearPer sharePaid outOf profit
2026$3.17$381M8%
2025$2.75$345M10%
2024$2.40$314M10%
2023$2.09$292M8%
2022$1.83$277M25%
2021$1.67$276Mn/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What McKesson Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 28, 2026
  2. August 5, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 7.7% to $105.4B versus the same quarter last year; diluted EPS $5.15 versus $6.25.
  3. August 5, 2026
  4. July 24, 2026
  5. July 1, 2026
  6. June 30, 2026
  7. June 12, 2026
  8. June 12, 2026
  9. June 12, 2026
  10. June 12, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 10, 2026. Insider transactions on SEC

What is MCK worth? A DCF from its reported cash flow

Insider trades

What the people running McKesson Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $367.5K worth of shares in the last 90 days and bought none on the open market. 27% of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$367.5K
last 90 days
Net sold
412
$367.5K
DateInsiderWhatSharesPriceValueFiling
September 8, 2026 Rutledge Napoleon B JRSVP, Controller & CAO Soldpre-planned (10b5-1) 111 $891.45 $99K Form 4
August 10, 2026 Lerman Bradley EDirector Sold 301 $892.33 $268.6K Form 4
July 22, 2026 Martinez MariaDirector Received as pay 277 $814.04 $225.5K Form 4
July 22, 2026 Caruso Dominic JDirector Received as pay 277 $814.04 $225.5K Form 4
July 22, 2026 Wilson-Thompson KathleenDirector Received as pay 277 $814.04 $225.5K Form 4
July 7, 2026 Tyler Brian S.Chief Executive Officer, Director Soldpre-planned (10b5-1) 8,463 $793.56 $6.7M Form 4
June 17, 2026 Tyler Brian S.Chief Executive Officer, Director Soldpre-planned (10b5-1) 8,463 $775.13 $6.6M Form 4
June 9, 2026 Tyler Brian S.Chief Executive Officer, Director Soldpre-planned (10b5-1) 4,929 $763.00 $3.8M Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns MCK

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Vanguard Capital Management13G, passive 7.49% 9,180,981 April 30, 2026

Latest filings below 5%: The Vanguard Group 0% (March 27, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 2,011 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.10,795,054$8.16B-623,330
Vanguard Capital Management LLC7,853,137$5.93B-107,587
State Street Corp5,727,118$4.33B-4,638
Morgan Stanley5,306,142$4.01B+3,006,517
Franklin Resources Inc2,905,114$2.2B-158,031
Vanguard Portfolio Management LLC2,873,217$2.17B-9,851
Geode Capital Management, LLC2,822,155$2.12B-81,693
Massachusetts Financial Services Co2,446,386$1.86B-453,847
Fmr LLC2,130,288$1.61B-1,473,135
Alliancebernstein L.P.1,686,993$1.46B-553,704
Jpmorgan Chase & Co1,748,860$1.31B-1,519,480
Arrowstreet Capital, Limited Partnership1,551,950$1.17B+239,786
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main1,538,910$1.16B+491,826
Norges Bank1,529,056$1.16Bnew
Northern Trust Corp1,442,340$1.09B-19,841
Bank of America Corp1,321,991$998.9M-216,735
Goldman Sachs Group Inc1,321,129$998.2M+16,048
Royal Bank of Canada1,283,310$969.7M+985
Boston Partners1,169,676$886.4M+14,627
Nordea Investment Management AB1,004,498$752.9M+16,452

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

10 insiders reported holding 47,000 shares in total, about $43M at the last price.

HolderSharesAs of
Vitalone Britt J.EVP & CFO 21,953 May 23, 2026
Fraga FranciscoEVP, CIO and CTO 6,210 May 23, 2026
Tyler Brian S.Chief Executive Officer, Director 5,919 July 7, 2026
Smith LeAnn BEVP & Chief HR Officer 4,798 June 1, 2026
Lau MicheleEVP and Chief Legal Officer 3,247 May 26, 2026
Rodgers Thomas LEVP, Chief Strategy & BDO 2,268 June 2, 2026
Caruso Dominic JDirector 927 July 22, 2026
Wilson-Thompson KathleenDirector 578 July 22, 2026
Martinez MariaDirector 578 July 22, 2026
Rutledge Napoleon B JRSVP, Controller & CAO 521 September 8, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about MCK

What does McKesson Corp do?

McKesson distributes pharmaceuticals, medical supplies, and healthcare technology solutions. It sells prescription drugs and care management tools to retail pharmacies, hospitals, clinics, and health systems. It is known for managing medical supply chains across North America. Its shares trade on NYSE under the ticker MCK.

What is McKesson Corp's net worth?

McKesson Corp has a market value (market cap) of $106.7B at the latest share price, and shareholders' equity of -$4.2B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is McKesson Corp profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $4.6B on revenue of $411B, a net margin of 1.1%.

How much revenue does McKesson Corp make?

Over the twelve months to June 30, 2026 McKesson Corp reported revenue of $411B. That is 8.8% more than a year earlier.

When did McKesson Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 10, 2026.

When is McKesson Corp's next earnings report?

McKesson Corp's next report was expected around September 17, 2026 and is not on file with the SEC yet.

Does McKesson Corp pay a dividend?

Yes. McKesson Corp declared dividends of $3.17 per share in fiscal 2026, a yield of 0.35% at the current price.

Similar companies

Compare MCK with

Compare MCK with any company

Follow MCK

Get an email when McKesson Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow MCK: get an email when it files

Where the numbers come from

Financial figures are the values McKesson Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.